4507 ORAL Axitinib (AG-013736; AG) in patients (pts) with metastatic clear cell renal cell cancer (RCC) refractory to sorafenib
Authors:
- B. RiniBRB. Rini
- G. WildingGWG. Wilding
- G. HudesGHG. Hudes
- W.M. StadlerWSW.M. Stadler
- S. KimSKS. Kim
- J. TaraziJTJ. Tarazi
- P. BycottPBP. Bycott
- K. LiauKLK. Liau
- J. DutcherJDJ. Dutcher
- 1 September 2007
- journal article
- abstracts
- Published by Elsevier in European Journal of Cancer Supplements
- Vol. 5 (4) , 300